Clinical Trial Update: Phase II Study of Zidovudine and Recombinant Alpha-2A Interferon in the Treatment of Patients With AIDS-Associated Kaposi's Sarcoma [Phase 2]

View source ↗

Summary

Phase II trial evaluating zidovudine with recombinant alpha-2A interferon for AIDS-associated Kaposi's sarcoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Kaposi Sarcoma

Drugs mentioned

• Recombinant alpha-2A interferon (interferon alfa-2a)
• Zidovudine (Zidovudine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Sarcoma, Kaposi, HIV Infections | Phase 2 | Status: COMPLETED